Cargando…
Modulation of Intestinal Corticotropin-Releasing Hormone Signaling by the Herbal Preparation STW 5-II: Possible Mechanisms for Irritable Bowel Syndrome Management
Corticotropin-releasing factor (CRF) mediates stress responses and alters the gut-brain axis, contributing to the pathogenesis of irritable bowel syndrome (IBS), which is recognized by abdominal pain accompanied by bowel habit disturbance. STW 5-II, a mixture of six herbal extracts, is clinically ef...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504045/ https://www.ncbi.nlm.nih.gov/pubmed/36145342 http://dx.doi.org/10.3390/ph15091121 |
_version_ | 1784796117513273344 |
---|---|
author | Elbadawi, Mohamed Ammar, Ramy M. Rabini, Sabine Klauck, Sabine M. Efferth, Thomas |
author_facet | Elbadawi, Mohamed Ammar, Ramy M. Rabini, Sabine Klauck, Sabine M. Efferth, Thomas |
author_sort | Elbadawi, Mohamed |
collection | PubMed |
description | Corticotropin-releasing factor (CRF) mediates stress responses and alters the gut-brain axis, contributing to the pathogenesis of irritable bowel syndrome (IBS), which is recognized by abdominal pain accompanied by bowel habit disturbance. STW 5-II, a mixture of six herbal extracts, is clinically effective in functional dyspepsia and IBS. Here we aimed to establish an organoid-based stress-induced IBS-like model to investigate the mechanisms of action of STW 5-II. STW 5-II (10, 20, and 30 g/mL) was applied to intestinal organoids for 24 h before being treated with CRF (100 nM) for 48 h. The effects of STW 5-II on CRF signaling were investigated using several in vitro and in silico approaches. STW 5-II activities were further explored by in silico PyRx screening followed by molecular docking of the main 52 identified compounds in STW 5-II with both CRF receptors CRFR1 and CRFR2. CRF exposure stimulated inflammation and increased proinflammatory mediators, while STW 5-II dose-dependently counteracted these effects. STW 5-II inhibited CRF-induced claudin-2 overexpression and serotonin release. Docking of the STW 5-II constituents oleanolic acid and licorice saponin G2 to CRFR1 and CRFR2, respectively, showed a good affinity. These multi-target activities support and elucidate the clinically proven efficacy of STW 5-II in disorders of gut-brain interaction. |
format | Online Article Text |
id | pubmed-9504045 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95040452022-09-24 Modulation of Intestinal Corticotropin-Releasing Hormone Signaling by the Herbal Preparation STW 5-II: Possible Mechanisms for Irritable Bowel Syndrome Management Elbadawi, Mohamed Ammar, Ramy M. Rabini, Sabine Klauck, Sabine M. Efferth, Thomas Pharmaceuticals (Basel) Article Corticotropin-releasing factor (CRF) mediates stress responses and alters the gut-brain axis, contributing to the pathogenesis of irritable bowel syndrome (IBS), which is recognized by abdominal pain accompanied by bowel habit disturbance. STW 5-II, a mixture of six herbal extracts, is clinically effective in functional dyspepsia and IBS. Here we aimed to establish an organoid-based stress-induced IBS-like model to investigate the mechanisms of action of STW 5-II. STW 5-II (10, 20, and 30 g/mL) was applied to intestinal organoids for 24 h before being treated with CRF (100 nM) for 48 h. The effects of STW 5-II on CRF signaling were investigated using several in vitro and in silico approaches. STW 5-II activities were further explored by in silico PyRx screening followed by molecular docking of the main 52 identified compounds in STW 5-II with both CRF receptors CRFR1 and CRFR2. CRF exposure stimulated inflammation and increased proinflammatory mediators, while STW 5-II dose-dependently counteracted these effects. STW 5-II inhibited CRF-induced claudin-2 overexpression and serotonin release. Docking of the STW 5-II constituents oleanolic acid and licorice saponin G2 to CRFR1 and CRFR2, respectively, showed a good affinity. These multi-target activities support and elucidate the clinically proven efficacy of STW 5-II in disorders of gut-brain interaction. MDPI 2022-09-08 /pmc/articles/PMC9504045/ /pubmed/36145342 http://dx.doi.org/10.3390/ph15091121 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Elbadawi, Mohamed Ammar, Ramy M. Rabini, Sabine Klauck, Sabine M. Efferth, Thomas Modulation of Intestinal Corticotropin-Releasing Hormone Signaling by the Herbal Preparation STW 5-II: Possible Mechanisms for Irritable Bowel Syndrome Management |
title | Modulation of Intestinal Corticotropin-Releasing Hormone Signaling by the Herbal Preparation STW 5-II: Possible Mechanisms for Irritable Bowel Syndrome Management |
title_full | Modulation of Intestinal Corticotropin-Releasing Hormone Signaling by the Herbal Preparation STW 5-II: Possible Mechanisms for Irritable Bowel Syndrome Management |
title_fullStr | Modulation of Intestinal Corticotropin-Releasing Hormone Signaling by the Herbal Preparation STW 5-II: Possible Mechanisms for Irritable Bowel Syndrome Management |
title_full_unstemmed | Modulation of Intestinal Corticotropin-Releasing Hormone Signaling by the Herbal Preparation STW 5-II: Possible Mechanisms for Irritable Bowel Syndrome Management |
title_short | Modulation of Intestinal Corticotropin-Releasing Hormone Signaling by the Herbal Preparation STW 5-II: Possible Mechanisms for Irritable Bowel Syndrome Management |
title_sort | modulation of intestinal corticotropin-releasing hormone signaling by the herbal preparation stw 5-ii: possible mechanisms for irritable bowel syndrome management |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504045/ https://www.ncbi.nlm.nih.gov/pubmed/36145342 http://dx.doi.org/10.3390/ph15091121 |
work_keys_str_mv | AT elbadawimohamed modulationofintestinalcorticotropinreleasinghormonesignalingbytheherbalpreparationstw5iipossiblemechanismsforirritablebowelsyndromemanagement AT ammarramym modulationofintestinalcorticotropinreleasinghormonesignalingbytheherbalpreparationstw5iipossiblemechanismsforirritablebowelsyndromemanagement AT rabinisabine modulationofintestinalcorticotropinreleasinghormonesignalingbytheherbalpreparationstw5iipossiblemechanismsforirritablebowelsyndromemanagement AT klaucksabinem modulationofintestinalcorticotropinreleasinghormonesignalingbytheherbalpreparationstw5iipossiblemechanismsforirritablebowelsyndromemanagement AT efferththomas modulationofintestinalcorticotropinreleasinghormonesignalingbytheherbalpreparationstw5iipossiblemechanismsforirritablebowelsyndromemanagement |